The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1461
ISSUE1461
February 2, 2015
Bunavail: Another Buprenorphine/Naloxone Formulation for Opioid Dependence
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Bunavail: Another Buprenorphine/Naloxone Formulation for Opioid Dependence
February 2, 2015 (Issue: 1461)
The FDA has approved a buccal film formulation of the
partial opioid agonist buprenorphine combined with
the opioid antagonist naloxone (Bunavail – BioDelivery
Sciences) for maintenance treatment of opioid
dependence. Sublingual tablet and film...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.